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AbstrAct
Objective  To develop and validate a contemporary 
clinical risk score to predict mortality after percutaneous 
coronary intervention (PCI).
Methods  Using data collected from patients undergoing 
PCI at the South Yorkshire Cardiothoracic Centre, Sheffield, 
UK, between January 2007 and September 2013, a 
risk score was developed to predict mortality. Logistic 
regression was used to evaluate the effect of each variable 
upon 30-day mortality. A backwards stepwise logistic 
regression model was then used to build a predictive 
model. The results were validated both internally and 
externally with data from Manchester Royal Infirmary, 
UK. 30-Day mortality status was determined from the UK 
Office of National Statistics.
Results  The development data set comprised 6522 
patients from Sheffield. Five risk factors, including 
cardiogenic shock, procedural urgency, history of renal 
disease, diabetes mellitus and age, were statistically 
significant to predict 30-day mortality. The risk score 
was validated internally on a further 3290 patients 
from Sheffield and externally on 3230 patients from 
Manchester. The discrimination of the model was high 
in the development (C-statistic=0.82, 95% CI 0.79 to 
0.85), internal (C-statistic=0.81, 95% CI 0.76 to 0.86) and 
external (C statistics=0.90, 95% CI 0.87 to 0.93) cohorts. 
There was no significant difference between observed and 
predicted mortality in any group.
Conclusion  This contemporary risk score reliably 
predicts 30-day mortality after PCI using a small number 
of clinical variables obtainable prior to the procedure, 
without knowledge of the coronary anatomy.
IntroductIon
Risk scores to predict mortality after percu-
taneous coronary intervention (PCI) have 
been present for decades. Initially designed 
to aid patient decisions, more recently, they 
have been used to allow for adjustment of 
operator and institutional mortality statistics 
and protect against risk-averse behaviour and 
litigation.1 2 Several risk scores can predict 
mortality, some using a large number of 
variables, some of which are not obtainable 
prior to angiography, some not reflecting 
contemporary PCI practice and others locally 
valid but untested elsewhere.3–11 A contem-
porary risk score comprising few, simpler 
variables, available to the operator prior to 
starting PCI, especially because many PCI 
procedures are conducted in an acute setting, 
would be ideal.
Key questIons
What is already known about this subject?
 ► There are numerous risk scores that exist to 
predict mortality post-percutaneous coronary 
intervention (PCI). The area is well studied and 
multiple authors have found that  numerous 
variables significantly predict both in-hospital and 
30-day mortality. But they are rarely used. Why? 
Most are too complex and do not use exclusively 
clinical variables readily available before taking 
the patient to the catheterisation laboratory.
What does this study add?
 ► In this study, we show that an accurate estimation 
of 30-day mortality post-PCI can be achieved with 
a relatively small number (five) of variables that 
are all obtainable prior to intervention.
How might this impact on clinical practice?
 ► We envisage that the risk score described here 
would allow patients and doctors to be fully 
informed before the procedure. We also foresee 
that the model would be an appropriate tool to 
protect operators from falsely elevated adverse 
outcome statistics, and to protect patients from 
risk-averse behaviour. The risk score could also be 
used to help stratify mortality data for operators 
and centres. Uniquely among risk scores that 
predict 30-day mortality, the model described 
here is unlikely to be incomplete or impossible to 
calculate, owing to the small number of readily 
ascertainable variables.
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The objective of this study was to develop and vali-
date, both internally and externally, a preprocedural risk 
score that is valid in the modern era, and predicts 30-day 
mortality post-PCI.
Methods
data collection
The original data set comprised all patients who under-
went PCI at the South Yorkshire Cardiothoracic Centre, 
Sheffield, UK. Sheffield is a tertiary centre providing all 
the PCI procedures for a population of ~1.8 million in 
the north of England. A standard panel of risk factors 
derived from previous risk scores was recorded using a 
dedicated database. This was a retrospective analysis of 
a prospectively kept database. The patient cohort was 
randomly divided into development (two-thirds) and 
validation (one-third) data sets and their 30-day mortality 
was determined from the UK Office of National Statistics. 
External validation was then performed by recalibrating 
the risk score using a technique described by Wu et al3 
and applying it to similar data from Manchester Royal 
Infirmary, Manchester, UK.
clinical variables and outcomes
Demographic and clinical data comprising a number 
of clinically relevant risk factors were collected prospec-
tively. Diabetes mellitus included both insulin-dependent 
and non-insulin-dependent types. Renal disease was 
labelled when serum creatinine was >200 µmol/L at 
the beginning of the PCI procedure, the patient was 
on regular dialysis or had undergone renal transplant; 
the absence of proof of renal disease was labelled as no 
history of renal disease. Cardiogenic shock was defined as 
signs of hypoperfusion (cold peripheries, altered mental 
state and oliguria) with a systolic blood pressure <90 mm 
Hg or one maintained artificially. Procedural urgency 
was categorised as elective, urgent or emergent: elective 
were planned procedures performed on stable patients; 
urgent were procedures performed on inpatients for 
unstable angina or non-ST segment elevation myocar-
dial infarction; emergent procedures were immediate 
procedures usually performed for ST segment elevation 
myocardial infarction.
The study outcome was 30-day mortality of any cause.
statistical analysis
Logistic regression was used to evaluate the effect of each 
variable on 30-day mortality. Variables available prior to 
intervention found to affect 30-day mortality at univar-
iate analysis at the level p<0.10 were then entered into 
a backwards stepwise logistic regression model. The vari-
ables found to be still significant at the level p<0.10 were 
retained in the final model. Two models were created, 
the first using only patients for whom all variables found 
significant on univariate analysis were available, the 
second with imputed data in place of the missing vari-
ables. A Mersenne Twister random number generator was 
used to impute five estimations for each missing variable; 
the modal average was then used in place of the missing 
values. Analysis of the performance of the risk scores 
when applied to the development set was undertaken 
using a receiver operator characteristic curve C-statistic12 
to assess discrimination, and the Hosmer-Lemeshow 
goodness-of-fit test to assess calibration.13 The unimputed 
model was later used for a further internal validation 
which was undertaken by applying the risk score to 
patients from the Sheffield validation set and the results 
were analysed using identical techniques. This process 
was then repeated using the external (Manchester) vali-
dation cohort once the risk score was recalibrated to the 
data. Assessment of the models was undertaken using the 
data sets for which there was no missing risk model vari-
ables. All analyses were performed using SPSS V.21.0.
results
The baseline group comprised 10 169 patients from 
Sheffield who underwent PCI between January 2007 
and September 2013, of which 6779 were in the devel-
opment group and 3390 in the validation group. The 
external validation group was made up of 4899 patients 
from Manchester who underwent PCI between January 
2012 and December 2014. After exclusions of patients 
with incomplete data (see online supplementary table 1), 
6522 patients remained in the development set, 3290 in 
the internal validation set and 3230 patients in external 
validation set.
There were 171 (2.5%) deaths within 30 days in the 
development group (153 after exclusions (2.3%)), 75 
(2.3%) in the internal validation group after exclusions 
and 64 (2.0%) in the external validation group after 
exclusions. Characteristics of the three groups are shown 
in table 1.
At univariate analysis of the development set, five 
variables were found to significantly impact mortality: 
cardiogenic shock (OR=20.1, 95% CI 11.6 to 35.1), emer-
gent procedure (OR=10.5, 95% CI 5.8 to 19.0), history 
of renal disease (OR=5.0, 95% CI 2.6 to 9.5), diabetes 
(OR=1.6, 95% CI 1.1 to 2.4) and age (OR=1.1 for each 
year, 95% CI 1.0 to 1.1).
Missing data for 257 patients in the development set 
were imputed and the results were entered into a back-
wards stepwise logistic regression model. A similar model 
was produced excluding the 257 patients for whom all 
variable data were not present (n=6522); the results of 
which are shown in table 2.
The unimputed and imputed models performed 
similarly when applied to the development set. The 
discrimination of both models was high14 (unimputed: 
C-statistic=0.82, 95% CI 0.79 to 0.85, figure 1A; imputed: 
C-statistic=0.82, 95% CI 0.79 to 0.85, figure 1B) , and 
both models were well calibrated, predicting 157 and 162 
deaths, respectively; 153 were observed. Hosmer-Leme-
show p values of 0.71 (unimputed) and 0.32 (imputed) 
confirmed no significant difference between observed 
and predicted mortality for either model (unimputed, 
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figure 1C; imputed, figure 1D). As both models performed 
similarly well, the unimputed model was selected for 
further analysis.
Equation 1 shows the risk score derived from the unim-
puted backwards stepwise logistic regression, where p=the 
probability of death within 30 days of undergoing PCI.
Table 1 Patient characteristics for patients in the development (with and without exclusions), internal and external validation 
sets and crude 30-day mortality rates. Results for the internal and external validation cohorts were calculated after the 
exclusion of missing variables required for completing the risk score
Development set 
(without exclusions)
Development set (with 
exclusions) Internal validation set
External validation 
set
n % n % n % n %
Total count 6779 6522 3290 3230
Age Mean±SD 62.6±11.5 62.5±11.6 62.3±11.6 61.8±11.6
Missing 0 0 0 0 – – – –
Sex Male 4856 71.6 4682 71.8 2358 71.7 2360 73.1
Female 1923 28.4 1840 28.2 932 28.3 870 26.9
Missing 0 0 0 0 – – – –
Cardiogenic 
shock
Yes 63 0.9 57 0.9 23 0.7 56 1.7
No 6642 98 6465 99.1 3267 99.3 3174 98.3
Missing 74 1.1 0 0 – – – –
Diabetes mellitus Yes 955 14.1 934 14.3 473 14.4 675 20.9
No 5701 84.1 5588 85.7 2817 85.6 2555 79.1
Missing 123 1.8 0 0 – – – –
History of renal 
disease
Yes 106 1.6 103 1.6 36 1.1 113 3.5
No 6531 96.3 6419 98.4 3254 98.9 3117 96.5
Missing 142 2.1 0 0 – – – –
Previous MI Yes 1841 27.2 1784 27.4 907 27.6 828 25.6
No 4165 61.4 4039 61.9 2051 62.3 2263 70.1
Missing 773 11.4 699 10.7 332 10.1 139 4.3
Urgency Elective 2164 31.9 2095 32.1 996 30.3 992 30.7
Urgent 2171 32.0 2135 32.7 1114 33.9 894 27.7
Emergent 2444 36.1 2292 35.1 1180 35.9 1344 41.6
Missing 0 0 0 0 – – – –
30-daymortality Dead 171 2.5 153 2.3 75 2.3 64 2.0
Alive 6608 97.5 6369 97.7 3215 97.7 3166 98.0
Missing 0 0 0 0 – – – –
MI, myocardial infarction.
Table 2 Results of the unimputed multivariate logistic regression model
Variable Coefficient OR
95 %
CIs p Value
Lower Upper
Cardiogenic shock 2.044 7.725 4.033 14.795 <0.001
Diabetes 0.378 1.459 0.947 2.246 0.086
History of renal disease 1.353 3.867 1.885 7.936 <0.001
Age 0.052 1.053 1.038 1.068 <0.001
Urgency (overall) <0.001
Urgent versus elective 0.585 1.795 0.887 3.632 0.104
Emergent versus elective 2.168 8.741 4.786 15.962 <0.001
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P = e
−8.673+0.052(Age)+2.044(CGS)+0.378(D)+1.353(HxR)+0.585(U1)+2.168(U2)
1+e−8.673+0.052(Age)+2.044(CGS)+0.378(D)+1.353(HxR)+0.585(U1)+2.168(U2) 
where Age, age of patient; CGS, presence (1) or absence 
(0) of cardiogenic shock; D, presence (1) or absence (0) 
of diabetes mellitus; HxR, presence (1) or absence (0) of 
a history of renal disease; U1 and U2, urgency of proce-
dure (elective: U1=0, U2=0; urgent U1=1, U2=0; emergent: 
U1=0, U2=1).
For example, a 75-year-old patient who presented 
in cardiogenic shock, had no history of diabetes or 
renal disease and was treated emergently would have 
log odds=−8.673 + 0.052*(75)+2.044 + 2.168=−0.561. This 
can be converted into a probability: p= e-0.561/1+e-0.561= 
0.363 (36.3%).
The risk model was then applied to the internal vali-
dation set. The discrimination of the model was high 
(C-statistic=0.81, 95% CI 0.76 to 0.86; figure 2A) and 
the model was well calibrated, because the risk score 
predicted 77 deaths and 73 occurred. A Hosmer-Leme-
show p=0.39 confirmed no significant difference between 
observed and predicted mortality (figure 2B).
The model was then recalibrated and applied to the 
external validation set. The discrimination of the model 
was high (C-statistic=0.90, 95% CI 0.87 to 0.93; figure 3A) 
and the model was well calibrated; predicted deaths=64, 
observed=64. A Hosmer-Lemeshow p=0.07 confirmed no 
significant difference between observed and predicted 
mortality (figure 3B).
For ease of use, the risk score was then developed into 
a nomogram described in table 3 and figure 4.
dIscussIon
In this study, we have developed and validated a simple 
risk score that can predict 30-day mortality after PCI and 
does not require knowledge of the coronary anatomy. The 
final five variables that make up the risk score (cardio-
genic shock, advanced age, procedural urgency, history 
of renal disease and diabetes mellitus) are all known 
prior to intervention and are readily ascertainable.
The variables in the model have been shown to impact 
outcomes and are used in other risk scores.3–9 11 Cardio-
genic shock is one of the most powerful predictor of 
adverse outcomes.15 16 Increasing age is associated with 
an increase in cardiovascular mortality, as well as being 
Figure 1 (A) Illustration of the receiver operating characteristic (ROC) curve (discrimination) of the unimputed model on the 
development set data. C-statistic: 0.82 (95% CI 0.79 to 0.85). (B) Illustration of the ROC curve (discrimination) of the imputed 
model on the development set data. C-statistic: 0.82 (95% CI 0.79 to 0.85). (C) Illustration of the Hosmer-Lemeshow goodness-
of-fit test of mortality observed versus that predicted by the unimputed model by decile of predicted risk in the development 
set: p value=0.71. (D) Illustration of the Hosmer-Lemeshow goodness-of-fit test of mortality observed versus that predicted by 
the imputed model by decile of predicted risk in the development set: p value=0.32. PCI, percutaneous coronary intervention.
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a surrogate for comorbidities17 18 which have been asso-
ciated with an increased 30-day mortality post-PCI.19 20 
Urgency is used in the risk score as a surrogate for acuity 
of presentation which is associated with adverse outcomes. 
Renal impairment has been associated with an increase 
in mortality post-PCI.21 and diabetes mellitus confers an 
increased risk of cardiac mortality.22Left ventricular ejec-
tion fraction has been included as a variable in a number 
of scores to predict outcomes post-PCI.3 4 6 9 However, 
it was excluded from our analysis as it is seldom known 
prior to intervention.
A widely used PCI risk score in the UK is the North 
West Quality Improvement Programme (NWQIP) model, 
which was developed on data from over a decade ago. 
However, it is reassuring to observe that three out of five 
predictors in our model (age, urgency and cardiogenic 
shock) were also in the NWQIP model, despite a change 
in case mix, technology and management strategy over 
the intermediate years.5 Another model widely used is 
US-based New York risk score and its more contempo-
rary iteration published in 2013. The strength of this 
model includes derivation form a very large data set 
(n=46 090 and n=54 223, respectively). However, due to 
differences in population mix and management between 
the USA and Europe including UK, the risk scores may 
not necessarily be applicable to non-US practice. Integer 
risk scores such as the Toronto score are no longer neces-
sitated in the modern era of computed recording and 
prediction.6 Nevertheless, we also found common vari-
ables between UK and North American scores.3 4 7
Figure 2 (A) Illustration of the receiver operating characteristic (ROC) curve (discrimination) of the model on the internal 
validation set data. C-statistic: 0.81 (95% CI 0.76 to 0.86). (B) Illustration of the Hosmer-Lemeshow goodness-of-fit test for 
observed versus predicted mortality by decile of predicted risk in the internal validation set: p value= 0.39. PCI, percutaneous 
coronary intervention.
Figure 3 (A) Illustration of the receiver operating characteristic (ROC) curve (discrimination) of the recalibrated model 
on the external validation set data. C-statistic: 0.90 (95% CI 0.87 to 0.93). (B) Illustration of the Hosmer-Lemeshow 
goodness-of-fit test for observed versus predicted mortality by decile of predicted risk in the external validation set: 
p value=0.07. PCI, percutaneous coronary intervention.
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With the exception of the model produced by McAl-
lister et al, no complete prediction of outcome can be 
ascertained prior to intervention, using only clinical vari-
ables. The model took advantage of a large data set and 
was developed using results from multiple centres across 
the UK. Both models include age, diabetes, renal disease, 
indication/urgency and cardiogenic shock as predictors 
of outcome. Interestingly, our model compares favour-
ably (validation C-statistic: 0.86 vs 0.90, (95% CI 0.87 to 
0.93); H-L: both non-significant) despite requiring four 
fewer variables suggesting that the data that were used to 
develop the model is in line with UK practice and could 
therefore potentially be applied widely.11 Overall, the 
performance of the model was favourable in comparison 
with all other risk scores that predict outcome post-PCI 
in terms of discriminating between those who did and 
did not die within 30 days (C-statistic) and in terms of 
predicted versus observed 30-day mortality (non-signifi-
cant Hosmer- Lemeshow).3–9 11
There was an increase in the discrimination ability 
of the model described here in the external validation 
cohort (C-statistic=0.90, 95% CI 0.87 to 0.93) compared 
with the development cohort (C-statistic=0.82, 95% CI 
0.78 to 0.85) and the internal validation cohort (C-sta-
tistic=0.81, 95% CI 0.76 to 0.86). The slightly higher 
discrimination in the external cohort may be the play 
of chance. However, following reviewer's comments, we 
looked at the patient characteristics in the three groups 
and found that patients in the external cohort had 
higher proportion of cardiogenic shock (development: 
0.9%, internal validation: 0.7%, external validation: 
1.7%), diabetes mellitus (development: 14.3%, internal 
validation: 14.4%, external validation: 20.9%) and history 
of renal disease (development: 1.6%, internal valida-
tion: 1.1%, external validation: 3.5%), all of which are 
included in the risk model. This may have resulted in 
better discrimination in this cohort.
study limitations
The risk model is based on data from a single centre; 
however, it was validated in another UK centre. Second, 
the numbers of patients included, while large for an 
Table 3 A table to calculate the risk of a specific patient. To be used in conjunction with figure 4
Patient
variables
Preliminary score 
value Final score valueCardiogenic shock Diabetes mellitus
History of renal 
disease Urgency
Yes Yes Yes Emergency −2.73 Add 0.052xage to 
preliminary score 
value
Urgent −4.313
Elective −4.898
No Emergency −4.083
Urgent −5.666
Elective −6.251
No Yes Emergency −3.108
Urgent −4.691
Elective −5.276
No Emergency −4.461
Urgent −6.044
Elective −6.629
No Yes Yes Emergency −4.774
Urgent −6.357
Elective −6.942
No Emergency −6.127
Urgent −7.71
Elective −8.295
No Yes Emergency −5.152
Urgent −6.735
Elective −7.32
No Emergency −6.505
Urgent −8.088
Elective −8.673
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individual centre, are limited by comparison with 
national data. Third, adverse events were relatively rare 
among the cohort. Finally, patients for whom variables 
were missing were not included in the study, though 
the congruence between the unimputed and imputed 
models derived from the development set suggest that 
missing variables in the development cohort were 
missing at random. More general limitations include 
the inability to predict an individual’s risk with a high 
level of accuracy, and the ignorance of rare but signifi-
cant predictors of outcome such as advanced metastatic 
disease. For these reasons, this risk score should only 
be used to guide clinical decisions, not make them, 
though the risk score may have a role in the adjust-
ment of operator and institutional mortality statistics 
and protection against risk-averse behaviour and litiga-
tion.1 2 The inherent complexity of multivariate logistic 
regression often, as in this case, leads to a complicated 
equation. Some authors have dealt with this problem 
by rounding the OR of a variable to an integer. But 
variables are routinely entered into a database that is 
capable of computing a non-integer risk score, so this 
may be an unnecessary simplification. We also devel-
oped a nomogram so a crude estimation of risk could 
be estimated with a relatively simple calculation.
clinical implications
There are numerous existing risk scores to predict 
adverse outcomes after PCI, but this risk score is the only 
recent model that predicts 30-day mortality using only 
five variables that are known prior to intervention.3–9 11 
The model described here offers a quick and reliable risk 
prediction that can help PCI operators to make more 
informed decision. The use of variables known prior to 
intervention also allows patients to be fully informed 
before they consent to an invasive procedure with poten-
tial risks. In the current era, where PCI outcomes are 
available to public scrutiny, a risk score is the appropriate 
tool to protect operators from falsely elevated adverse 
outcome statistics, and to protect patients from risk-averse 
decisions.2 23 We believe that in modern practice, there is 
little added advantage of an integer score. To make calcu-
lation easy, we are aiming to develop a mobile/desktop 
application (app) for this score, which can truly be used 
at the bedside. In summary, we have developed and vali-
dated a clinical risk score for PCI which is easy to use 
prior to intervention in modern practice.
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